Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: The MOSAIC randomised controlled trial

Thorax

Volumn 67, Issue 12, 2012, Pages 1090-1096

  Craig, Sonya Elizabeth ^a   Kohler, Malcolm ^b   Nicoll, Debby ^a   Bratton, Daniel J ^c   Nunn, Andrew ^c   Davies, Robert ^a   Stradling, John ^a,d  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE;

ADULT; ARTICLE; CANADA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ACTIVITY; EPWORTH SLEEPINESS SCALE; FEMALE; FOLLOW UP; HEALTH STATUS; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SLEEP DISORDERED BREATHING; SMOKING; SOMNOLENCE; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 84869239716     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202178     Document Type: Article

References (35)

1. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002;162:893-900. (Pubitemid 34299121)
2. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004;291:2013-16. (Pubitemid 38544284)
3. Martin SE, Engleman HM, Kingshott RN, et al. Microarousals in patients with sleep apnoea/hypopnoea syndrome. J Sleep Res 1997;6:276-80. (Pubitemid 28044153)
4. Rees K, Spence DPS, Earis JE, et al. Arousal responses from apneic events during non rapid-eye-movement sleep. Am J Respir Crit Care Med 1995;152:1016-21.
5. Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol 2005;25:117-29. (Pubitemid 40471632)
6. McDaid C, Duree KH, Griffin SC, et al. A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Med Rev 2009;13:427-36.
7. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomized, controlled trial. Ann Intern Med 2001;134:1015-23. (Pubitemid 32488655)
8. Robinson GV, Smith DM, Langford BA, et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006;27:1229-35. (Pubitemid 44914309)
9. Ali NJ, Davies RJO, Fleetham JA, et al. The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea. Chest 1992;101:1526-32.
10. Lovett JK, Rothwell PM. Site of carotid plaque ulceration in relation to direction of blood flow: an angiographic and pathological study. Cerebrovasc Dis 2003;16:369-75. (Pubitemid 37140426)
11. Robinson GV, Pepperell JC, Segal HC, et al. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004;59:777-82. (Pubitemid 39215375)
12. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 2003;7:35-51. (Pubitemid 36188305)
13. Alonso-Fernandez A, Garcia-Rio F, Arias MA, et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 2009;64:581-6.
14. Kohler M, Pepperell JC, Casadei B, et al. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 2008;32:1488-96.
15. Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004;160:521-30. (Pubitemid 39215628)
16. Sanders MH, Givelber R. Sleep disordered breathing may not be an independent risk factor for diabetes, but diabetes may contribute to the occurrence of periodic breathing in sleep. Sleep Med 2003;4:349-50.
17. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-5.
18. Mazza S, Pepin JL, Naegele B, et al. Most obstructive sleep apnoea patients exhibit vigilance and attention deficits on an extended battery of tests. Eur Respir J 2005;25:75-80. (Pubitemid 40207734)
19. Bennett LS, Stradling JR, Davies RJO. A behavioural test to assess daytime sleepiness in obstructive sleep apnoea. J Sleep Res 1997;6:142-5. (Pubitemid 27300273)
20. Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
21. Flemons WW, Reimer MA. Development of a disease-specific health-related quality of life questionnaire for sleep apnea. Am J Respir Crit Care Med 1998;158:494-503. (Pubitemid 28378179)
22. Euroquol Group. Euroquol - A new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
23. Pocock SJ, McCormack V, Gueyffier F, et al. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 2001;323:75-81. (Pubitemid 32681971)
24. Jenkinson C, Davies RJ, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100-5. (Pubitemid 29278478)
25. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-10. (Pubitemid 34113817)
26. Weatherly HL, Griffin SC, Mc DC, et al. An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome. Int J Technol Assess Health Care 2009;25:26-34.
27. Mulgrew AT, Ryan CF, Fleetham JA, et al. The impact of obstructive sleep apnea and daytime sleepiness on work limitation. Sleep Med 2007;9:42-53. (Pubitemid 350192902)
28. Powell NB, Schechtman KB, Riley RW, et al. Sleepy driver near-misses may predict accident risks. Sleep 2007;30:331-42.
29. Kohler M, Smith D, Tippett V, et al. Predictors of long-term compliance with continuous positive airway pressure. Thorax 2010;65:829-32.
30. McArdle N, Devereux G, Heidarnejad H, et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159: 1108-14. (Pubitemid 29202543)
31. Siccoli MM, Pepperell JC, Kohler M, et al. Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial. Sleep 2008;31:1551-8.
32. Barbe F, Duran-Cantolla J, Capote F, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010;181:718-26.
33. Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 2012;307:2161-68.
34. Senn O, Brack T, Matthews F, et al. Randomized short-term trial of two autoCPAP devices versus fixed continuous positive airway pressure for the treatment of sleep apnea. Am J Respir Crit Care Med 2003;168:1506-11. (Pubitemid 38037337)
35. Engleman HM, Kingshott RN, Wraith PK, et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:461-7. (Pubitemid 29084866)